Article Text

Download PDFPDF
Progressing neuropalliative care
  1. Emma Husbands
  1. Palliative Medicine, GHNHSFT, Gloucester, UK
  1. Correspondence to Dr Emma Husbands, Palliative Medicine, GHNHSFT, Gloucester, GL1 3NN, UK; emma.husbands{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The human experience will always be integral to our clinical practice. Dr Arani Nitkunan, consultant in neurology, eloquently describes the impact that her elderly aunt, Sinnamma, had on her approach to patient care.1 As a consultant in palliative medicine, I have always believed that the provision of palliative care, in the form of symptom control or comfort measures, should run alongside any disease-modifying treatment and that this, as with end-of-life care, is ‘everybody’s business’. In the UK, ‘end of life’ is defined as the expected last 12 months of life but it is often thought to refer only to the dying phase. Across progressive neurological conditions, the rate of change, potential for disease-modifying approaches and nature of symptoms will vary but in real terms, almost all of these conditions are incurable and therefore …

View Full Text


  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests Member of the International Neuropalliative Care Society.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

  • A patient that changed my practice
    Arani Nitkunan

Other content recommended for you